<DOC>
	<DOCNO>NCT02744664</DOCNO>
	<brief_summary>This trial design assess efficacy safety Cryotherapy combine Icotinib Advanced NSCLC Patients harbor EGFR mutation .</brief_summary>
	<brief_title>Cryotherapy Combine Icotinib Advanced NSCLC Treatment</brief_title>
	<detailed_description>In single arm clinical study , enrol patient , advanced stage NSCLC confirm epidermal growth factor receptor ( EGFR ) mutation , would receive cryotherapy tumor begin Icotinib , EGFR tyrosine kinase inhibitor administration thereafter . Progression free survival , overall survival safety wil observe .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Histological cytological confirmation nonsmall cell lung cancer ( NSCLC ) phase 3B/4 ; Life expectancy ≥12weeks . Eastern Cooperative Oncology Group ( ECOG ) performance status 01 . The number target lesion whole body ≤ 8 ( number lung lesion ≤ 5 , big one 's diameter≤ 7 cm , number liver lesion ≤ three big one 's diameter ≤ 5 cm . Adequate hematological function : hemoglobin ≥90g/L ( blood transfusion 14 day ) Absolute neutrophil count ( ANC ) ≥1.5 * 109/L , Platelet count ≥75 x 10^9/L . Adequate renal function : Serum creatinine ≤1.5 * upper limit normal ( ULN ) , Serum creatinine≥ 50 ml/min . Adequate liver function : Total bilirubin ≤ 2 *ULN Alanine Aminotransferase ( ALT ) Aspartate Aminotransferase ( AST ) &lt; 2.5 * ULN absence liver metastasis , &lt; 5 * ULN case liver metastasis . Female subject pregnant . All human subject able comply require protocol followup procedure , able receive oral medication Written inform consent provide . Previous usage EGFRTKI antibody EGFR : gefitinib , erlotinib , herceptin , erbitux . Allergic Icotinib . Lack physical integrity upper gastrointestinal tract , malabsorption syndrome , inability take oral medication , active peptic ulcer disease . Pregnancy breastfeed woman . Any unstable systemic disease ( include active infection , uncontrolled hypertension , unstable angina , congestive heart failure , myocardial infarction 6 month , serious cardiac arrhythmia require medication , hepatic , renal , metabolic disease ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Lung Neoplasms</keyword>
	<keyword>EGFR mutation</keyword>
	<keyword>Cryotherapy</keyword>
	<keyword>Icotinib</keyword>
</DOC>